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Relationships between paraspinal muscle
morphology and neurocompressive
conditions of the lumbar spine: a
systematic review with meta-analysis
Jeffrey R. Cooley1* , Bruce F. Walker1, Emad M. Ardakani 1, Per Kjaer 2, Tue S. Jensen3,4,5 and Jeffrey J. Hebert6,7
Abstract
Background: Individual study results have demonstrated unclear relationships between neurocompressive disorders
and paraspinal muscle morphology. This systematic review aimed to synthesize current evidence regarding the
relationship lumbar neurocompressive disorders may have with lumbar paraspinal muscle morphology.
Methods: Searches were conducted in seven databases from inception through October 2017. Observational studies
with control or comparison groups comparing herniations, facet degeneration, or canal stenosis to changes in imaging
or biopsy-identified lumbar paraspinal muscle morphology were included. Data extraction and risk of bias assessment
were performed by review author pairs independent of one another. Morphological differences between individuals
with and without neurocompressive disorders were compared qualitatively, and where possible, standardised mean
differences were obtained.
Results: Twenty-eight studies were included. Lumbar multifidus fiber diameter was smaller on the side of and below
herniation for type I [SMD: −0.40 (95% CI = −0.70, −0.09) and type II fibers [SMD: −0.38 (95% CI = −0.69, −0.06)]
compared to the unaffected side. The distribution of type I fibers was greater on the herniation side [SMD: 0.43 (95% CI
= 0.03, 0.82)]. Qualitatively, two studies assessing small angular fiber frequency and fiber type groupings demonstrated
increases in these parameters below the herniation level. For diagnostic imaging meta-analyses, there were no
consistent differences across the various assessment types for any paraspinal muscle groups when patients with
herniation served as their own control. However, qualitative synthesis of between-group comparisons reported greater
multifidus and erector spinae muscle atrophy or fat infiltration among patients with disc herniation and radiculopathy
in four of six studies, and increased fatty infiltration in paraspinal muscles with higher grades of facet joint
degeneration in four of five studies. Conflicting outcomes and variations in study methodology precluded a clear
conclusion for canal stenosis.
Conclusions: Based on mixed levels of risk of bias data, in patients with chronic radiculopathy, disc herniation and severe
facet degeneration were associated with altered paraspinal muscle morphology at or below the pathology level. As the
variability of study quality and heterogeneous approaches utilized to assess muscle morphology challenged comparison
across studies, we provide recommendations to promote uniform measurement techniques for future studies.
Trial registration: PROSPERO 2015: CRD42015012985
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Background
Globally, low-back pain (LBP) ranks first in years lived with
disability [1]. The lifetime prevalence of LBP is estimated to
be as high as 84% [2], with a mean of 38.9% [3]. In
Australia, 2001 estimates revealed a direct and indirect cost
of LBP of AUD$9.17 billion [4]. In 2014, the estimated an-
nual cost of chronic LBP-related lost productivity in Japan
was ¥1.2 trillion (equivalent to AUD$12.6 billion) [5]. It
should be noted that these estimated prevalence rates and
costs are inclusive of all types of LBP; however, approxi-
mately 90% of LBP is non-specific in nature, while specific
LBP resulting from an identifiable disorder (e.g., tumor,
fracture, stenosis) can only be classified in a small percent-
age of patients [6]. Although there is very limited data avail-
able to quantify the prevalence of neuro-compressive
disorders such as lumbar disc herniation, facet joint hyper-
trophy and lumbar spinal stenosis, these can only make up
a portion of the 10% of specific LBP cases.
Despite intensive research efforts aimed at enhancing
our understanding of both specific and non-specific LBP,
these disorders continues to present diagnostic and
therapeutic challenges. In an attempt to identify discrete
pain generating tissues or clinically relevant structural
changes related to LBP, recent studies have focused on
the relationships between morphological changes to the
lumbar paraspinal musculature (e.g., atrophy, fat replace-
ment) and both specific and non-specific causes of
chronic low back or radicular pain [7–11]. Systematic re-
views have assessed the relationship of paraspinal muscle
morphology with LBP, the impact of paraspinal muscle
atrophy and/or fatty replacement on clinical outcomes,
and the predictive value of paraspinal muscle morph-
ology with clinical outcomes [12–14].
Of particular interest to this review is the growing
body of research attempting to identify the relationships
between spinal pathologies and paraspinal muscle
morphology, and their impact on specific LBP and
clinical outcomes [15–21]. One specific area of interest
focuses on localized injuries or pathologies resulting in
nerve root or central neurological compression (neuro-
compressive disorders), as it is understood that the bio-
logical effects of short and long-term skeletal muscle
denervation can result in muscle fiber atrophy and adi-
pose tissue replacement [22–24]. However, no prior sys-
tematic reviews of these relationships have been
identified by the authors. A 2014 review by Steffens et
al. [25], explored the ability of MRI-identified patholo-
gies to predict future LBP, concluding that no definitive
associations between imaging findings and clinical out-
comes could be confirmed due to limited research in
this area. However, these authors did not include altered
muscle morphology in their pathology criteria, nor did
they look at the relationship of paraspinal muscle
morphology to regional pathology.
Therefore, the objective of this study was to systemat-
ically review the literature to investigate for relationships
between lumbosacral neurocompressive disorders and
measures of lumbar paraspinal muscle morphology in
patients with specific LBP.
Methods
Protocol and registration
This review followed the reporting guidelines and method-
ologies proposed in Preferred reporting items of systematic
reviews and meta-analysis: the PRISMA statement [26] and
Meta-analysis of observational studies in epidemiology
(MOOSE) [27]. The initial review protocol was registered
with Prospero, 13 February 2015 (PROSPERO 2015
:CRD42015012985), available from: http://www.crd.york.a-
c.uk/PROSPERO/display_record.asp?ID=CRD42015012985.
The original search strategy was applied following the regis-
tered protocol; however, due to the large and diverse num-
ber of articles meeting the eligibility criteria, a post-hoc
decision was made to the original protocol to limit this re-
view to patients with radicular pain or reduced muscle
strength in the lower extremities due to neurocompression.
Information sources
With the assistance of specialist librarians, we developed
a search strategy using medical subject headings (MeSH)
and keywords that encompassed muscle type and
morphology; pathology and related clinical syndromes;
imaging types, biopsy analyses, and muscle measurement
parameters; and, the lumbar spinal region. No language
restrictions were applied.
We searched the following databases from inception
through October 2017 in PEDro, PubMed (Medline),
Web of Science (Core Collection), Web of Science
(Medline Advanced), SPORTDiscus, Cumulative Index
to Nursing and Allied Health Literature (CINAHL), and
EMBASE. The reference lists of included studies from
the title/abstract screening, as well as all systematic re-
views related to the topic, were also reviewed. Where
only an abstract was published as part of a poster or
conference proceedings, the authors were contacted via
email to determine if the full studies had since been
published. The search protocols for each database can
be found in Additional file 1.
Eligibility and study selection criteria
The eligibility and selection criteria are provided in
Table 1. The outcomes of interest included measures of
lumbar paraspinal muscle morphology, such as muscle
cross-sectional area, fat infiltration area, and type I and
II muscle fiber distribution.
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Study selection and data extraction
Selection process
One reviewer (JC) conducted all database searches based
on the previously defined strategies and removed all du-
plicates (Figure 1). Two review authors (JC/EA) inde-
pendently screened all included titles & abstracts
according to the eligibility criteria, and articles denoted
as potentially eligible by either reviewer (i.e., “yes” or
“maybe”) were included for the full-text screening stage.
Articles were excluded if both reviewers indicated “no”.
As there were no language restrictions applied to the
search, all non-English articles selected for full-text re-
view were professionally translated [Straker Translations
(Melbourne, Victoria; Australia)].
Four reviewers participated in the full-text screening
phase (JC reviewed all articles in conjunction with either
EA, BW, or JH to ensure each article was initially inde-
pendently assessed by two reviewers). A selection form
(developed using EpiData Manager v2.0.4.43 [EpiData
Association, Denmark]) was developed and piloted on
ten citations, then modified for clarity (Additional File
2). Once trained, viewers assessed full-text copies of the
selected articles according to the selection criteria. For
full article inclusion, both reviewers of an article had to
note “yes”. For exclusion, both reviewers had to indicate
“no” and the recorded reason(s) agreed. Any disagree-
ment or uncertainty regarding a decision at this stage of
the process which could not be resolved by the two re-
viewers was presented to a third review author (i.e., an
author not involved in the initial full-text review of the
article) for final determination.
Extraction process
A data extraction form was developed using EpiData
Manager (v2.0.4.43 – EpiData Association, Denmark)
and pre-tested by the lead reviewer. All reviewers under-
went training in the use of the form, which resulted in
minor modifications to enhance clarity. Pairs of review
authors independently extracted the data. Additional file
2 provides specific details regarding the type of data ex-
tracted. When extracting data, if details were not speci-
fied in the methods or results sections, “not included”
was input by the reviewers.
Following extraction, a consensus meeting was held
with each pair of reviewers to ensure accuracy and
agreement between reviewers. Where differences were
identified, disagreements were resolved via discussion or
upon consultation with a third reviewer. Additionally, to
identify studies potentially reporting duplicate data once
the extracted data was tabulated, the lead reviewer
cross-checked the study authors, year of publication,
dates of data acquisition (if provided), study aims, par-
ticipant demographics, methods for assessing muscle
changes, and outcomes being analysed. Inter-reviewer
agreement was examined by percentage agreement and
Kappa coefficients, using IBM SPSS Statistics v24.0
[Armonk, NY: IBM Corp.].
Risk of bias assessment
At the time this review was initiated, no established or
validated risk of bias (ROB) tool appropriate for the
types of studies predominately being assessed in this re-
view was available. As such, we developed a modified
version of the ROB tool developed by Downs and Black
[28]. With one exception, the modifications applied were
limited to removal of questions relating to interventions
(following the approach used by Mills et al. [29], and
Munn et al. [30]), and the replacement of guidance sce-
narios to better match the focus of our review. One
reporting criterion assessing for clear descriptions of in-
terventions was replaced with a criterion assessing for
clear descriptions of assessment parameters, to include
an otherwise absent key component of this review.
The three overarching criteria for assessing studies in-
cluded: 1) reporting characteristics (e.g., aims, methods,
participant characteristics, confounders, probability
values); 2) external validity (e.g., population representa-
tion, blinding, appropriateness of analysis); and, 3) internal
validity (e.g., recruitment, adjusting for confounders).
Additional file 3 details the ROB tool, including more de-
tailed explanations of the modifications applied.
The modified ROB tool for this review was piloted with
each review author using three articles. Five authors inde-
pendently assessed study quality (JC assessed all selected
studies; EA, BW, JH, and PK assessed one or more sub-
components ensuring two independent quality assessments
Table 1 Study eligibility and selection criteria
Inclusion criteria
Articles published (including those accepted for publication) in an
indexed, peer reviewed journal, or a publisheda thesis
Studies including patients with: disc herniation, facet arthrosis, and/or
spinal canal stenosis identified via imaging; specific LBP with confirmed
radicular leg pain or muscle weakness on clinical examination
Regional paraspinal muscle morphology assessed with imaging or
biopsy for either the lumbar multifidus muscles (LMM), erector spinae
muscles (ESM) (including subcomponents), psoas major muscles (PMM),
or "paraspinal / paravertebral" muscles (PVM)
Observational human studies with a control or comparison analyses
(controls included: "normal" or “non-diseased”; comparisons between
different severities of conditions; participants serving as own control
when there was a normal and an abnormal side to compare)
Clinical / surgical trials containing baseline data with relevant “pathology
to muscle” or “clinical to muscle” comparisons
Exclusion criteria
History of previous lumbar spine surgery
Analysis was solely post-interventional (i.e., no pre-surgical, pre-treatment,
or pre-activity/functional muscle measurement data analysed)
Case reports, editorials/letters, literature reviews, guidelines, and
abstract-only publications
Patients with primary muscular disease (e.g., muscular dystrophy,
parkinsonism)
aIf archived in an international research database (e.g., ProQuest, EBSCOhost)
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of each study). Disagreements within each reviewer pairing
were discussed and resolved by consensus. A third re-
viewer was available to resolve irreconcilable differences,
but this was not required. When analysing the quality of
data, one assumption was made regarding the reporting of
blinding: if no indication was discernible from a study’s
methodology that the investigator(s) extracting clinical data
were different from those assessing the imaging, it was
considered that no blinding occurred between the clinical
and imaging data acquisitions.
Due to the inherent issue of variable item weighting
when using scaled/score-based ROB tools, an a priori de-
cision was made to apply the study quality criteria used by
Munn et al. [30], of <60% (low quality / high risk), 60-74%
(moderate quality / moderate risk), and ≥75% (high quality
/ low risk) for determining overall study quality. While
other studies have set a score of 50% as a quality exclusion
criteria (e.g., Mills et al. [29]), we agreed with Munn that
60% was fair in our context; studies of low quality were
not excluded from analysis, but their potential for in-
creased risk of bias was considered and discussed where
applicable. Inter-reviewer reliability of risk of bias was ex-
amined by percentage agreement and Kappa coefficients.
Summary measures
For data where meta-analysis was possible, the reported
means and standard deviations were used to calculate
standardised mean differences (SMD). The SMD was used
to allow for direct comparison of pooled results between
the different continuous measurement metrics reported in
our included studies, as well as to compare different con-
structs between analyses (e.g., measured area versus ratios
Combined database searches:
PubMed (Medline): 2197
Web of Science (Core): 630
Web of Science (Advanced): 2051
PEDro: 627
SPORTDiscus: 127
Cinahl: 253
Embase: 1293
Total studies for title / 
abstract screening after 
duplicates removed:
4688
Total studies retained 
for full-text review: 
300
Total potential articles
for data extraction and 
qualitative analysis: 
113
Additional studies
from reference list 
search:  
33
Primary reason for excluding each 
study:
• Control/comparison groups not clearly
defined; no pre-interventional control
analysis; no control group comparison
performed (75)
• Conference abstract / poster – no article
published; published under different title (23)
• All participants healthy / asymptomatic; no
specific abnormalities assessed (19)
• Prior history of low back surgery; prior history 
of surgery not stated as exclusion criteria
(12)
• Predominate findings outside of the low back; 
combined multi-spinal region analysis (11)
• Functional muscle analysis only (9)
• Descriptive analysis only; no analysis
between muscle changes and clinical
presentation (9)
• Primary neuromuscular disease; conditions
assessed not included in this review (8)
• Spinal region not defined (5)
• Did not assess paraspinal muscles;
combined analysis with non-paraspinal
muscles (5)
• Other (11)
Assessed by 
imaging
[Total {pooled}]: 
20 {4}
Neuro-compression
analysis: 
28 [27]
Assessed by 
biopsy 
[Total {pooled}]:
7 {4}
Conditions excluded from this
analysis:†
• Low back pain (50)
• Mechanical stress (due to
abnormal alignment) (19)
• Degenerative disc disease (no
disc herniation) (7)
• Idiopathic postural  conditions (5)
• Ankylosing spondylitis (5)
• Other (7)
Fig. 1 Flow diagram for search strategy. †Some articles included conditions assessable in more than one subcategory
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or percentages). For non-pooled data, the reported mea-
sures were retained and analysed descriptively.
Methods of analysis
For this review we undertook qualitative and quantita-
tive analysis. For quantitative analysis, after evaluating
the study outcomes for clinical homogeneity, we per-
formed a random-effects meta-analysis on the included
studies, assessing for statistical heterogeneity using both
χ2 and I2 statistics. The SMD (95% CI), calculated with
Hedges’ g, was used to report parameter estimates.
Criteria to assess clinical homogeneity between studies
included patient source, sex, age, chronicity of symptoms
related to neurocompression, type of comparison, imaging
or biopsy method, muscle parameters assessed, and out-
come scales. Meta-analyses were undertaken when three
or more homogeneous studies were available. As the study
effect sizes were collected from a distribution of variable
effect sizes, the random-effects model was applied. Statis-
tical analyses were conducted using Review Manager
(RevMan) v5.3 [Copenhagen: The Nordic Cochrane
Centre, The Cochrane Collaboration, 2014.].
Additional analyses
Pre-specified subgroup analyses comprised disc hernia-
tions and studies with low risk of bias. A post-hoc deci-
sion was made to assess for differences in outcomes
between muscle biopsy sites located at and below the
level of disc herniation.
The percentage difference in muscle fiber diameter be-
tween the affected and unaffected sides of patients with
LDH was calculated as the average mean diameter on the
affected side / average mean diameter on the unaffected side
x 100. The “average mean diameter” (AMD) per side was de-
termined by the formula: AMD = [(m*N (S1)) + (m*N (S2))
+ (m*N (S3)) + (m*N (S4))] / Total N [S = study].
Results
Study selection
The database searches identified 7178 studies, with 2490
being duplicates (Figure 1). A total of 267 studies were se-
lected from the title/abstract search, and an additional 33
studies were identified from the reference list search of all
selected articles and relevant reviews. Nine non-English
language articles were included (Chinese (5), Turkish,
Portuguese, Japanese, and German), of which eight met the
requirements for full-text review and were fully translated.
The number of studies excluded (with primary reasons in-
dicated) at the full-text screening stage is noted in Figure 1.
A list of excluded studies from the full-text phase is pro-
vided in Additional file 4.
Twenty-three potential studies for inclusion were initially
identified as abstracts-only from conference proceedings or
poster presentations. Upon further investigation, four of
these were published under a different title and were
already included for review. Authors of 15 additional ab-
stracts were contacted with a request to confirm if their
study had proceeded to full publication. Eight authors re-
plied to either an initial or follow-up request; of these, seven
indicated no publication had occurred and one provided
publication details under a different title already included.
No contact details for any of the authors listed for four of
the abstracts could be identified. No additional studies were
added from this process.
There were 113 studies initially identified for potential
data extraction, of which 28 focussed on conditions relat-
ing to neurocompression. The remaining studies were ex-
cluded from this report (Figure 1), but will be considered
for future systematic reviews. Of the studies identified for
extraction, two [31, 32] were noted to provide different
analyses of the same data set and were combined, redu-
cing the number of distinct studies to 27. Two additional
studies were published by the same lead author drawing
patients from the same facility [22, 33]; however, there
were sufficient differences in the methodology and patient
demographics to consider these as distinct studies.
For the full-text screening phase, we achieved moder-
ate inter-rater agreement (κ ≥ 0.68) [34] (Table 2). A
third reviewer was only required on one occasion to
clarify the presence of a control group.
Study characteristics
Additional file 5 provides specific extracted participant
characteristics and study details. Patients with lumbar
disc herniation (LDH) were assessed via imaging in 12
studies [15, 16, 18, 35–43] and via biopsy in six studies
[22, 33, 44–47], with one additional study [48] assessing
subjects en bloc via biopsy across multiple pathologies
Table 2 Full text screening and risk of bias agreement
Agreement for full text screening
Examiners
1 & 2
Examiners
1 & 3
Examiners
1 & 4
Overall
N (articles) 126 65 88 279
% agreement 83% 88% 86% 86%
κ
[CI (95%)]
0.68
[0.53-0.80]
0.75
[0.58-0.91]
0.73
[0.57-0.86]
0.71
[0.63-0.80]
Agreement for risk of bias analysis
ROB section Reporting External
Validity
Internal
Validity
Overall
N (questions)a 224 168 84 476
% agreement 83% 81% 73% 81%
κ
[CI (95%)]
0.51
[0.38-0.63]
0.63
[0.52-0.74]
0.43
[0.28-0.62]
0.58
[0.51-0.65]
κ Kappa coefficient, CI confidence intervals, N number of questions
aBased on number of questions asked per section x 28 articles selected for
neurocompression subgroup
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with or without nerve root involvement (LDH being
most frequent). Using MR or CT imaging, three studies
assessed patients with facet arthrosis [49–51], four stud-
ies assessed patients with canal stenosis [20, 52–54], and
two studies assessed both facet arthrosis and canal sten-
osis [31, 32]. These latter two studies (although eventu-
ally combined for analysis) reported outcomes separately
for arthrosis and stenosis, allowing data to be assessed
for each condition.
Risk of bias within studies
During initial risk of bias analysis, overall inter-rater
agreement was weak (Table 2). However, complete agree-
ment was reached on all items during the first consensus
meeting, without the need for third reviewer arbitration.
The risk of bias indices showed a wide variation in po-
tential study bias (Table 3). Studies utilizing imaging
methods to assess muscle changes tended to show lower
risk of bias than those using biopsy [13.9/19 (imaging)
versus 12.1/19 (biopsy)].
Risk of bias across studies
Figure 2 provides a graphic breakdown of potential bias
across studies. The four areas of risk most consistently
identified related to: a) uncertainty regarding recruited
population representation, with most studies failing to
provide sufficient descriptive data to make a determin-
ation; b) lack of reporting of actual probability values,
with newer studies more likely to provide these values;
c) distribution of principal confounders, with nearly half
the studies providing only partial details; and d) blinding.
An inherent blinding challenge existed for the
imaging-based studies – even if the examiner measuring
the muscles was blinded to the imaging pathology re-
port, the pathology would most likely be evident on the
images if it was not specifically blocked from view.
Study findings with syntheses of results
For each of the following sections, a compilation of the
relevant outcome details for the included studies is pro-
vided in Additional file 5. Attempts were made via email
to contact authors when issues with study data required
clarification. In two cases details were not obtained, one
reporting anatomically improbable measurement ranges
for some data [37], and one with missing error values
for some outcomes [33]. In both instance these data
were removed from analysis.
Paraspinal muscle morphology in patients with lumbar disc
herniation (LDH) – assessed with imaging
Study characteristics and ROB Twelve studies assessed
patients with unilateral LDH with radiculopathy; 11
using MRI and one using diagnostic ultrasound. Of
these, six had a low risk of bias, three a moderate risk,
and three a high risk; total sample sizes varied from 33
to 165 participants. In four studies, patients served ex-
clusively as their own controls (involved vs uninvolved
sides) [15, 18, 35, 41], two studies used both patients
and healthy volunteers as controls [37, 42], and one
study used the patients and healthy volunteers as con-
trols plus included an LDH group without radiculopathy
as a comparison [38]. One study compared acute versus
chronic radiculopathy patients as well as using patients
in each group as their own controls [16], while another
study used healthy participants as the only control [39].
Two studies used low back pain patients without LDH
or nerve root compression as a comparison – one
chronic [36] and one non-specific [43], and the final
study used chronic low back pain patients with degen-
erative disc disease (DDD) without LDH as a compari-
son [40]. All but one study assessed the lumbar
multifidus muscles (LMM) (with or without including
the erector spinae muscles (ESM)) and four studies in-
cluded the psoas major muscles (PMM). Multiple mea-
sures of muscle morphology were used in most studies,
with the total cross-sectional area (TCSA) and/or func-
tional cross-sectional area (FCSA) being most consist-
ently assessed.
Meta-analysis Four studies met our criteria for pooled
data analysis assessing for differences in mean LMM
TCSA [15, 16, 38, 41] (refer to Additional file 5 for study
details). For those measures taken at the level of LDH, 166
patients with unilateral LDH where included but demon-
strated no significant difference in the pooled SMD be-
tween sides (Figure 3a). A total of 90 patients were
included for measurements below the level of LDH, also
showing no differences (Figure 3b). As there were diverse
outcomes between studies, subgroup analyses were under-
taken to determine if this was dependent on the duration
of symptoms; however, the pooled SMD remained
non-significant [at the level of LDH – only acute included
[0.14 (95% CI = −0.16, 0.45] and acute excluded [−0.17
(95% CI = −0.47, 0.14)]; below the level of LDH – only
acute included [0.04 (95% CI = −0.38, 0.46)] and acute ex-
cluded [−0.03 (95% CI = −0.50, 0.44)]].
Three of these studies also met the criteria for assessing
differences in the mean FCSA and FCSA:TCSA ratios [15,
38, 41]. For FCSA measures taken at or below the level of
LDH, 90 patients with unilateral LDH where included; the
pooled SMD again demonstrated no difference between
sides (Figures 4a and 4b). A total of 90 patients were also
included for FCSA:TCSA ratio measures at and below the
level of LDH. While all studies demonstrated smaller mean
measures on the affected side at both levels, no significant
difference in the pooled SMD between sides was found
(Figures 5a and 5b). Table 4 (section 1.0) reports the
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qualitative synthesis results from relevant studies not in-
cluded in the meta-analyses.
Paraspinal muscle morphology in patients with lumbar disc
herniation – assessed with biopsy
Study characteristics and ROB Six studies assessed pa-
tients with unilateral LDH with radiculopathy using muscle
biopsy. Of these, one was of high quality, four of moderate
quality, and one of low quality; study sample sizes ranged
from 17 – 117. In four studies, patients served exclusively
as their own controls (involved vs. uninvolved sides) [22,
33, 45, 47], and in two studies recently deceased persons
who were previously healthy served as the control group
[44, 46]. All studies assessed the LMM, with one study [45]
also assessing the ESM. Although various measurement pa-
rameters were used across studies, they all included the
mean fiber type distribution and diameter.
Meta-analysis All four studies with patients serving as
their own control met the criteria for pooled data analysis
when assessing mean fiber type diameter of the LMM.
These studies measured type I and II fiber diameter (μm) at
a total of 112 spinal levels in 83 unilateral LDH patients
undergoing surgical intervention, with each study including
both acute and chronic patients (refer to Additional file 5
for additional study details). The pooled analysis demon-
strated a reduction of type I fiber diameter on the side of
LDH (Figure 6a), which equated to the average mean diam-
eter being 5.5% smaller on the side of LDH; similar results
were seen for type II fiber diameter (Figure 6b), with the
average mean diameter being 6.8% smaller on the side of
LDH. The study by Ford et al. [45], contradicted the find-
ings of the other three studies for both fiber types, but it
was the lowest quality study and provided the least details
regarding the relationship of the LDH to the muscle level
biopsied.
Three of the above studies also met the criteria for
pooling the assessment of differences in the mean fiber
type distribution [22, 45, 47]. Although none of these
studies reported a significant difference in fiber distribu-
tion individually, their pooled SMD demonstrated an in-
crease in type I fiber distribution on the side of LDH
(Figure 6c), which equated to a 7% greater average mean
fiber distribution. The fourth study was not included in
fiber distribution pooled data analysis due to the absence
of a reported variance estimate which could not be ob-
tained from the authors; however, consistent with the
pooled data it did report a higher mean distribution of
type I fibers on the side of LDH [33].
Fig. 2 Risk of bias across studies. *Low risk of bias: ROB tool criteria = Yes; Unclear risk of bias: ROB tool criteria = Partial or Unable to be
determined; High risk of bias: ROB tool criteria = No
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a
Study or 
Subgroup
Affected
Mean SD Total
Unaffected
Mean       SD  Total Weight
Std Mean 
Difference IV,  
Random, 95% CI
Std Mean Difference
IV, Random, 95% CI
Battie (2012)[15] 7.8 1.9 43 7.6 1.8 43 47.9% 0.11 [−0.32, 0.53]
Fortin (2016)[41] 5.4 1.9 33 5.5 2.0 33 36.8% −0.05 [−0.53, 0.43]
Hyun (2007)[38] 440.17 181.98 14 509.55 190.98 14 15.3% −0.36 [−1.11, 0.39]
Total (95% CI) 90 90 100.0% −0.02 [−0.32, 0.27]
Heterogeneity: Tau² = 0.00; Chi² = 1.16, df = 2 (P = 0.56); I² = 0%
Test for overall effect: Z = 0.15 (P = 0.88) AFFECTED  UNAFFECTED
b
Study or 
Subgroup
Affected
Mean  SD Total
Unaffected
Mean     SD  Total Weight
Std Mean 
Difference IV, 
Random, 95% CI
Std Mean Difference
IV, Random, 95% CI
Battie (2012)[15] 7.6 2.3 43 7.9 2.0 43 47.8% −0.14 [−0.56, 0.29]
Fortin (2016)[41] 5.9 1.8 33 6.1 1.8 33 36.8% −0.11 [−0.59, 0.37]
Hyun (2007)[38] 348.02 240.44 14 420.33 244.66 14 15.4% −0.29 [−1.03, 0.46]
Total (95% CI) 90 90 100.0% −0.15 [−0.44, 0.14]
Heterogeneity: Tau² = 0.00; Chi² = 0.16, df = 2 (P = 0.92); I² = 0%
Test for overall effect: Z = 1.01 (P = 0.31) AFFECTED UNAFFECTED
Fig. 4 Pooled LMM imaging measurements – FCSA. Pooled functional cross-sectional area (FCSA) measures for meta-analysis comparing the side
affected by disc herniation to the unaffected side. 4a: at the level of herniation; 4b: below the level of herniation
a
Study or 
Subgroup
Affected
Mean SD Total
Unaffected
Mean       SD Total Weight
Std Mean 
Difference IV,  
Random, 95% CI
Std Mean Difference
IV, Random, 95% CI
Battie (2012)[15] 9.9 2.2 43 9.5 2.0 43 25.9% 0.19 [−0.24, 0.61]
Fortin (2016)[41] 9.6 2.1 33 9.4 1.8 33 20.0% 0.10 [−0.38, 0.58]
Hyun (2007)[38] 649.68 142.32 14 709.64 156.44 14 8.4% −0.39 [−1.14, 0.36]
Kim (2011)(acute)[16] 680.1 171.9 39 664.7 156.6 39 23.6% 0.09 [−0.35, 0.54]
Kim (chronic)[16] 632.9 123.0 37 675.3 133.9 37 22.1% −0.33 [−0.79, 0.13]
Total (95% CI) 166 166 100.0% −0.01 [−0.23, 0.20]
Heterogeneity: Tau² = 0.00; Chi² = 4.06, df = 4 (P = 0.40); I² = 2%
Test for overall effect: Z = 0.13 (P = 0.90) AFFECTED UNAFFECTED
b 
Study or 
Subgroup
Affected
Mean         SD  Total
Unaffected
Mean         SD  Total Weight
Std Mean 
Difference IV,  
Random, 95% CI
Std Mean Difference
IV, Random, 95% CI
Battie (2012)[15] 11.0 2.6 43 10.9 2.4 43 48.0% 0.04 [−0.38, 0.46]
Fortin (2016)[41] 11.7 2.3 33 11.4 1.9 33 36.7% 0.14 [−0.34, 0.62]
Hyun (2007)[38] 586.78 209.65 14 677.12 262.16 14 15.3% −0.37 [−1.12, 0.38]
Total (95% CI) 90 90 100.0% 0.01 [−0.28, 0.31]
Heterogeneity: Tau² = 0.00; Chi² = 1.29, df = 2 (P = 0.53); I² = 0%
Test for overall effect: Z = 0.09 (P = 0.93)
AFFECTED 
UNAFFECTED
Fig. 3 Pooled LMM imaging measurements – TCSA. Pooled total cross-sectional area (TCSA) measures for meta-analysis comparing the side
affected by disc herniation to the unaffected side. 3a: at the level of herniation; 3b: below the level of herniation
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For the above analyses, only the measurements at the
level below herniation were used from the Yoshihara et
al. (2001) study [22]; results taken at the level of LDH
were also available, but rather than combining the two
sets of values, the latter dataset was included in a subse-
quent subgroup analysis based on the level of biopsy in
relation to LDH. As the study by Ford et al., did not spe-
cify this relationship, it was excluded from further ana-
lysis. For biopsies acquired at [22, 47] or below [22, 33]
the level of LDH, type I and II fiber diameter measures
were only smaller on the affected side for muscles below
the level of LDH: type I fiber diameter at the level of
LDH (SMD [95% CI] = −0.27 [−0.68, 0.13]) and below
the LDH (SMD [95% CI] = −0.53 [−0.95, −0.11]); type II
fiber diameter at the level of LDH (SMD [95% CI] =
−0.30 [−0.71, 0.10]) and below the LDH (SMD [95% CI]
= −0.57 [−0.99, −0.16]). There was insufficient data to
perform subgroup analysis on fiber type distribution.
Table 4 (section 1.1) shows results from the qualitative
synthesis for this section.
Paraspinal muscle morphology in patients with any spinal
pathology and associated nerve root signs – assessed with
biopsy
One study assessed the distribution of LMM fiber types
in patients with spinal pathology with and without signs
of NR involvement, along with a cadaveric control group
[48]. The limited distinction of pathology types pre-
cluded pathology-based analysis. Although a significant
difference was demonstrated in the percentage of type II
fibers, both measures fell within the average type II fiber
distribution of ~36% (±11%) noted by Mannion et al.
[55], in a young, healthy population. This was the oldest
and highest risk of bias study in this systematic review
(7/19).
Paraspinal muscle morphology in patients with facet
arthrosis – assessed with imaging
Study characteristics and ROB Four studies looked at
three different data sets utilizing CT imaging to assess
fatty infiltration of paraspinal muscles in individuals with
facet arthrosis: two from the same general population
[31, 32] and two from patient populations [49, 50].
Three studies were of high quality and one of moderate
quality; total sample sizes varied from 100-187. Three
studies assessed facet arthrosis and muscle changes at
multiple spinal levels; one study evaluated the L4/5 level
only [49]. Three studies evaluated the LMM and ESM
and compared participants with arthrosis to those with-
out; the remaining study assessed the LMM, PMM, and
longissimus and assessed arthrosis on a summative grad-
ing scale [50]. A fifth, moderate quality study used MRI
and CT to assess CSA and fatty infiltration of the LMM
[51]. All studies applied different statistical analyses to
the relationships between arthrosis and muscle changes,
precluding data pooling. Table 4 (section 1.3) provides
the results from the qualitative synthesis for this section.
a
Study or 
Subgroup
Affected
Mean SD Total
Unaffected
Mean       SD  Total Weight
Std Mean 
Difference IV,  
Random, 95% CI
Std Mean Difference
IV, Random, 95% CI
Battie (2012)[15] 0.78 0.09 43 0.8 0.07 43 47.7% −0.25 [−0.67, 0.18]
Fortin (2016)[41] 0.55 0.16 33 0.57 0.14 33 36.8% −0.13 [−0.61, 0.35]
Hyun (2007)[38] 0.68 0.23  14 0.73 0.24 14 15.5% −0.21 [−0.95, 0.54]
Total (95% CI) 90 90 100.0% −0.20 [−0.49, 0.10]
Heterogeneity: Tau² = 0.00; Chi² = 0.12, df = 2 (P = 0.94); I² = 0%
Test for overall effect: Z = 1.32 (P = 0.19) AFFECTED UNAFFECTED
b
Study or 
Subgroup
Affected
Mean  SD Total
Unaffected
Mean     SD  Total Weight
Std Mean 
Difference IV, 
Random, 95% CI
Std Mean Difference
IV, Random, 95% CI
Battie (2012)[15] 0.69 0.12 43 0.72 0.09 43 47.6% −0.28 [−0.71, 0.14]
Fortin (2016)[41] 0.51 0.11 33 0.53 0.11 33 36.8% −0.18 [−0.66, 0.30]
Hyun (2007)[38] 0.55 0.24  14 0.59 0.16 14 15.6% −0.19 [−0.93, 0.55]
Total (95% CI) 90 90 100.0% −0.23 [−0.52, 0.06]
Heterogeneity: Tau² = 0.00; Chi² = 0.11, df = 2 (P = 0.95); I² = 0%
Test for overall effect: Z = 1.53 (P = 0.13) AFFECTED UNAFFECTED
Fig. 5 Pooled LMM imaging measurements – FCSA:TCSA ratio. Pooled FCSA:TCSA ratio measures for meta-analysis comparing the side affected
by disc herniation to the unaffected side. 5a: at the level of herniation; 5b: below the level of herniation
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Paraspinal muscle morphology in patients with canal
stenosis – assessed with imaging
Study characteristics and ROB Six studies looked at
five different data sets to assess relationships between
central stenosis and muscle morphology, with four being
of high quality and two of moderate quality; total sample
sizes ranged from 35 – 345. Two studies used the same
CT data set to assess fatty infiltration of the LMM and
ESM in a general volunteer population [31, 32]. The
remaining studies evaluated patients with clinical and/or
imaging findings consistent with stenosis; one used CT
[52], two used MRI [20, 53], and one used MR spectros-
copy [54]. Of these latter four studies, one compared
spinal stenosis patients to LBP patients without spinal
stenosis as well as asymptomatic volunteers [20], one
compared stenosis to chronic LBP patients only [54],
while to remaining two studies compared patients with
and without stenosis only. Muscle analysis utilized a variety
of approaches and statistical analyses were also quite variable,
precluding the pooling of data. Table 4 (section 1.4)
reports the results from the qualitative synthesis data
for this section.
Discussion
This systematic review is the first to synthesize studies
examining the relationships between paraspinal muscle
morphology and spinal pathologies associated with neu-
rocompression in patients with specific LBP. We found
LDH to be associated with muscle morphological
changes comprising fiber size, fiber type, and fiber distri-
bution. Specifically, the findings of our meta-analyses
demonstrated that when patients served as their own
controls, LDH was associated with decreased type I and
II fiber size, and an increased proportion of type I fibers,
in the LMM at the level below the herniation; this could
a
Study or 
Subgroup
Affected
Mean  SD Total
Unaffected
Mean    SD Total Weight
Std Mean 
Difference IV, 
Random, 95% CI
Std Mean Difference
IV, Random, 95% CI
Ford (1983)[45] 58.9 16.7 18 58.8 8.3 18 22.3% 0.01 [−0.65, 0.66]
Yoshihara (2001)[22] 59.1 7.2 29 63.1 10.0 29 35.0% −0.45 [−0.97, 0.07]
Yoshihara (2003)[33] 58.1 7.5 17 63.6 8.5 17 19.8% −0.67 [−1.36, 0.02]
Zhao (2000)[47] 45.3 7.1 19 48.6 6.8 19 22.9% −0.46 [−1.11, 0.18]
Total (95% CI) 83 83 100.0% −0.40 [−0.70, −0.09]
Heterogeneity: Tau² = 0.00; Chi² = 2.15, df = 3 (P = 0.54); I² = 0%
Test for overall effect: Z = 2.51 (P = 0.01) AFFECTED UNAFFECTED
b
Study or 
Subgroup
Affected
Mean  SD Total
Unaffected
Mean  SD Total Weight
Std Mean 
Difference IV, 
Random, 95% CI
Std Mean Difference
IV, Random, 95% CI
Ford (1983)[45] 42.5 14.2 18 40.8 12.8 18 22.4% 0.12 [−0.53, 0.78]
Yoshihara (2001)[22] 40.5 8.1 29 44.9 7.3 29 34.2% −0.56 [−1.09, −0.04]
Yoshihara (2003)[33] 39.3 8.7 17 44.5 8.5 17 20.3% −0.59 [−1.28, 0.10]
Zhao (2000)[47] 33.3 7.0 19 36.5 8.6 19 23.2% −0.40 [−1.04, 0.24]
Total (95% CI) 83 83 100.0% −0.38 [−0.69, −0.06]
Heterogeneity: Tau² = 0.00; Chi² = 3.10, df = 3 (P = 0.38); I² = 3% 
Test for overall effect: Z = 2.35 (P = 0.02) AFFECTED UNAFFECTED
c
Study or 
Subgroup
Affected
Mean  SD Total
Unaffected
Mean  SD Total Weight
Std Mean 
Difference IV, 
Random, 95% CI
Std Mean Difference
IV, Random, 95% CI
Ford (1983)[45] 53.0 15.0 18 49.0 19.5 18 29.3% 0.22 [−0.43, 0.88]
Yoshihara (2001)[22] 66.0 6.7 29 60.6 7.1 29 40.0% 0.77 [0.24, 1.31]
Yoshihara (2003)[33] 60.2 12.9 19 58.1 11.6 19 30.7% 0.17 [−0.47, 0.80]
Total (95% CI) 66 66 100.0% 0.43 [0.03, 0.82]
Heterogeneity: Tau² = 0.03; Chi² = 2.59, df = 2 (P = 0.27); I² = 23%
Test for overall effect: Z = 2.10 (P = 0.04) AFFECTED UNAFFECTED 
Fig. 6 Pooled LMM biopsy measurements. Pooled biopsy measures for meta-analysis comparing the side affected by disc herniation to the
unaffected side. 6a: type I fiber size; 6b: type II fiber size; 6c: type I fiber distribution
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be related to compressive nerve root damage leading to
muscle fiber denervation [46]. From the qualitative syn-
thesis of individual studies (Table 4), we found a higher
frequency of small angular fibers (indicating denervation
of single motor neuron muscle fibers [46]) and fiber type
grouping (indicating collateral re-innervation of these fi-
bers [46]) on the side of and below LDH, which corre-
lated with the more significant amount of fiber atrophy
found at the level below herniation in the pooled data. A
higher percentage of core targetoid change was also
identified at the level below LDH in one study, which is
a non-specific indicator of underlying muscle disease, in-
cluding denervation [46]. The findings from the pooled
and non-pooled data suggest that persistent compression
of the nerve roots may be contributing to atrophy of
muscle fibers supplied by that nerve. Whether these
changes are permanent or reversible is unclear.
Pooling of data from studies that used imaging modal-
ities to measure the cross-sectional area of paraspinal
muscles did not identify associations with spinal path-
ology. However, several individual studies did report as-
sociations between spinal pathology and imaging derived
measures of paraspinal muscle morphology, particularly
regarding LDH with chronic radiculopathy, and facet ar-
throsis [31, 32, 35, 36, 38, 39, 43, 49, 51]. Increased fatty
infiltration of the PVM occurred with higher grades of
facet degeneration, particularly at L4/5 (where facet joint
arthrosis is most commonly found [56]). For central
canal stenosis, the limited number of studies, conflicting
outcomes, and key variations in study methodology pre-
cluded a definitive conclusion.
The absence of findings of a consistent reduction of
muscle CSA in the presence of these specific pathological
conditions may indicate that no significant relationships
exist; however, it may also be possible that the variability
in study designs is partially concealing the impact of the
changes. For example, mixing measures across spinal
levels rather than specifically measuring “at” and “below”
the herniation, measuring above the level of pathology,
grouping all spinal levels instead of individual analysis, or
mixing acute and chronic back pain patients in the same
analysis. Conversely, any number of study design or meas-
urement variations could also have resulted in the appar-
ent mismatch between the biopsy and imaging findings;
however, actual morphological reasons for this difference
may relate to fiber type distribution being less apparent
anatomically and thus only notable with biopsy, or the in-
ternal complexity of the gross anatomy of the LMM mask-
ing microscopic changes to individual fiber size on
imaging. Additionally, imaging modalities cannot provide
the same level of precision as histological studies.
Potential confounders to be considered when interpret-
ing the outcomes of this review include the neurological
supply of the multifidus muscles, how muscle atrophy
presents, and the types of controls used between studies.
When considering uni-segmental versus multi-segmental
nerve supply to the LMM, it is physiologically apparent
that muscle activation (whether normal or pathological)
can occur well above or below the level of primary nerve
root involvement, even if the anatomical data suggests
level-specific innervation [57]; however, Kottlors et al.
[57], have suggested that this effect reduces the further
away the level of muscle origin is from the nerve root af-
fected. If that is the case, the primary alteration to the
LMM from any nerve root lesion should be most pro-
found at the level supplied by the medial branch of the
dorsal ramus of the affected nerve root, with progressively
less change occurring to the muscles farther away. This
may help explain the occasional finding of reduced LMM
FCSA (albeit insignificantly) of the muscle above an af-
fected nerve root, but the greater likelihood of significant
FCSA reduction of muscles supplied primarily by a com-
pressed nerve root.
Within several studies, the side-to-side differences in
the reported TCSA were less consistent than those
noted for the FCSA. While muscle atrophy is most sim-
ply assessed by imaging as a reduction in the overall size
of a muscle’s TCSA, this does not take into account the
possibility that individual muscle fascicles may atrophy
and be replaced by fat infiltration [58] without reducing
the muscle’s total cross-section. This change may mani-
fest most clearly in the multifidus muscle fascicles clos-
est to the spinolaminar margins (as visualized on axial
cross-sections from L4-S1), which are directly innervated
by an affected L4 or L5 nerve root. This variability could
be accounted for in the assessment of atrophy if a
muscle-to-fat ratio component is included, and by in-
cluding all tissue within the epimysial boundaries.
The issue of using patients as their own controls, ver-
sus healthy (with imaging studies) or cadaveric controls
(for biopsy studies) was considered. The advantages of
using patients as their own controls includes consistency
of image parameters, quality, spinal level selection and
patient parameters (e.g., matching size, age, sex vari-
ables), as well as being generally more convenient since
fewer participants are required. Disadvantages include
the potential for inherent confounders, such as normal
asymmetry, any effect of the pathologic variable on the
contralateral side, or the potential for neurological alter-
ations contralateral to the side of pathology [57]. How-
ever, our review did not show outcomes to be greatly
varied between studies based on the type of control
group, except with biopsies using cadaveric controls.
Limitations
A key challenge for undertaking this review was the inher-
ent difficulty in assessing paraspinal muscle morphology
by any study looking at these muscle groups, due to a lack
Cooley et al. BMC Musculoskeletal Disorders  (2018) 19:351 Page 17 of 21
of agreement on multifidus muscle gross and neuroanat-
omy; at least ten published variations are described. The
2008 study by Lonnemann et al. [59], provides a clear
overview of these descriptions, but also offers a new one.
This is further complicated by a 2011 article by Cornwall
et al. [60], describing anatomy more closely found in the
seminal study by Macintosh et al. [61], but with their own
distinct alternations to that description. Nevertheless, the
Lonnemann [59] and Cornwall [60] studies both agree on
the complex inter-digitation or blending of the different
fascicles of the LMM, which makes distinction of individ-
ual fascicles on imaging exceedingly challenging. For our
review, this underlying anatomical complexity was further
compounded by a lack of focused measurement method-
ologies or agreed muscle degeneration criteria used in the
included studies. This resulted in a wide variety of ap-
proaches to investigate for associations between spinal
pathology and paraspinal muscles changes, with outcomes
that were difficult to compare or amalgamate for a more
robust statistical analysis. In this regard, our findings were
consistent with a recent narrative review by Kalichman et
al. [62], and a proposed paraspinal muscle analysis meth-
odology by Crawford et al. [63], each identifying a strong
need to establish uniform methods for evaluating para-
spinal muscle degeneration.
The limited quality assessment tool options for
cross-sectional studies created a challenge, and while no
generally accepted and valid tool was identified for look-
ing at the associations between pathology and muscle
changes, two options presented with the best potential:
that developed by Downs and Black [28], and the
Newcastle-Ottawa scale [64]. Although the
Newcastle-Ottawa scale was designed specifically for ob-
servational studies, it was lacking in several reporting
items we felt were important, was initially focussed on
cohort and case control studies, and was still in the val-
idation process. As both potential tools required modifi-
cation, we determined to use a modified version of the
Downs and Black risk of bias tool following the proto-
cols of other similar published reviews [29, 30]. We also
incorporated one additional modification by replacing a
“clearly described intervention” item with a “clearly de-
scribed assessment parameters” item, as we determined
this to be an important and equivalent quality issue for
our topic. These modifications may have had a small im-
pact on overall risk of bias analysis, but this should have
equally affected all studies. Varying degrees of familiarity
with the tool between examiners may also have contrib-
uted to some of the initial non-agreement in the ROB
analysis.
An insufficient number of studies were available to sta-
tistically assess for publication bias (e.g., funnel plots).
However, while there is a potential for positive publication
bias, the risk would seem fairly low in this review since
the studies were observational and non-interventional,
with no particular outcome from which those authors
would benefit. Additionally, the moderate level of initial
agreement for full text screening, and weak to moderate
level of initial agreement for ROB analysis may have con-
tributed to potential selection and/or quality bias; how-
ever, in the majority of cases the disagreement was either
due to one examiner overlooking or misinterpreting a
small inclusion/exclusion detail in a study, or related to
complexities regarding how information was reported in
relation to the ROB analysis criteria. In every case, full
consensus was reached at the first meeting, with a rela-
tively even mix of altered input between each examiner
such that no one assessor dominated the review outcome.
The small number of studies included in each
meta-analysis can reduce the precision of the estimate of
the between-studies variance; the summary effect size
results should be not be considered in isolation from the
qualitative analysis.
Finally, this review does not address the issue of caus-
ality between pathology or altered muscle morphology
and clinical findings. Additionally, in those instances
where an association between spinal pathology and al-
tered morphology was identified, no conclusions can be
reached regarding the potential future clinical impact of
these relationships.
Recommendations
The high variability of approaches utilized to measure
muscle morphology via imaging modalities created chal-
lenges for identifying any clear trends. In an attempt to
promote some level of uniformity to muscle measure-
ment techniques, in addition to and in conjunction with
the protocols proposed by Crawford et al. [63], the fol-
lowing are recommended: 1) measurement ratios are
preferable to standalone total or functional
cross-sectional area measures, as they help to account
for variations in individual patient anatomy and imaging
parameters; 2) when calculating total cross-sectional
area, measures should still include any central fat (i.e.,
measure to the vertebral arch boundaries for the multifi-
dus), as this accounts for the total replacement of
intra-epimysial muscle by fat; 3) when measuring func-
tional muscle area, all obvious intramuscular fat should
be excluded – this is potentially more time consuming,
but provides a truer indication of functional muscle; 4)
use of raw data from assessing muscle brightness (e.g.,
signal/density/echogenicity) is subject to variability be-
tween equipment and facilities – ratio differences in
brightness may help overcome this limitation; 5) mea-
surements should be analysed by individual spinal levels
and specified in relation to the level of spinal pathology,
as the data suggests this relationship to be of potential
importance; 6) although measurements at any spinal
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level are acceptable, studies should at minimum include
measures below the level of spinal pathology, particularly
for disc herniations; 7) as an individual’s age, sex, and to
a lesser degree BMI, all appear to have the potential to
influence the morphology and/or appearance of the vari-
ous paraspinal muscle groups, these three parameters
should be clearly identified and accounted for during
any analysis.
Conclusions
Histologically, there was recurring evidence that fiber
changes consistent with muscle denervation and
re-innervation were associated with LDH when the unin-
volved side muscles were used as the control. Insufficient
biopsy evidence was available to analyse for relationships
between arthrosis or stenosis and altered muscle fiber
morphology. With imaging, the only relatively consistent
finding was the apparent reduction in LMM functional
muscle on the side of LDH and radiculopathy as symp-
toms became more chronic; however, several studies failed
to separate acute from chronic patients in their analysis so
the true differences relating to chronicity are unclear. Fu-
ture studies should attempt to report and analyse chronic
and acute patients separately to address this issue. No
consistent imaging findings associated with LDH-related
changes to the PMM were identified. Increased severity of
facet arthrosis appeared to correlate with increased fatty
infiltration of the PVM at the level of arthrosis. Any asso-
ciations between spinal canal stenosis and altered muscle
morphology were inconclusive.
Although a number of studies have looked at the po-
tential impact of neurocompressive conditions on para-
spinal muscle morphology, uncertainty remains – in
large part due to the publication of a significant number
of moderate to high risk of bias studies, and the variabil-
ity of approaches used by these studies to assess for rela-
tionships. In patients with chronic radiculopathy,
neurocompressive disorders seem to alter muscle
morphology at or below the affected level. Future re-
search should include more uniform methods and our
proposed criteria may potentially improve the chance of
determining if there are any clinically relevant associa-
tions between spinal pathology and muscle atrophy.
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